Global Ankylosing Spondylitis Market Size study & Forecast, by Drug Class (NSAIDs, TNF Inhibitors and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Analysis, 2022-2029
Global Ankylosing Spondylitis Market is valued at approximately USD 5.38 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.6% over the forecast period 2022-2029. Ankylosing Spondylitis refers to an inflammatory disease that causes the bones in the spine (vertebrae) to fuse. This fusing affects the spine’s flexibility and can result in poor posture. If ribs are affected, it can be difficult to breathe deeply. Ankylosing Spondylitis symptoms include pain in the lower back, hips, and buttocks, stiffness in the lower back, hips, and buttocks. neck pain, ligament and tendon pain, tiredness, and night sweats among others. The growing prevalence of Arthritis and rising incidences of Ankylosing Spondylitis as well as strategic initiatives from leading market players are key factors accelerating the market growth.
The rising prevalence of Arthritis is contributing to the growth of the Global Ankylosing Spondylitis Market. For instance, according to Arthritis Foundation estimates – as of 2019, globally more than 54 million adults and approximately 300,000 children are affected by arthritis or another type of rheumatic disease. Moreover, increasing incidences of Ankylosing Spondylitis are also fueling up the growth of the Market. For instance, as per Spondylitis Association of America – as of 2020 more than 1.7 million adults in the U.S. are affected by AS. Whereas, around 3.2 million have a form of axial spondyloarthritis. Also, the rising number of orthopedic hospitals and diagnostic centers and growing healthcare infrastructure in developing regions would create lucrative growth prospects for the market over the forecast period. However, the high treatment cost associated with Ankylosing Spondylitis stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Ankylosing Spondylitis Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region in terms of market share due to factors such as the rising prevalence of Ankylosing Spondylitis as well as growing healthcare infrastructure in the region. Whereas the Asia Pacific is expected to grow with the highest CAGRduring the forecast period, owing to factors such as rising geriatric individuals as well as growing healthcare infrastructure in the region.
Major market player included in this report are:
AbbVie Inc.
Amgen, Inc,
Eli Lilly and Company
Gilead Sciences Inc.
Janssen Pharmaceuticals
Merck & Co. Inc
Novartis AG,
Pfizer, Inc
Reliance Life Sciences Pvt. Ltd
UCB, Inc.,
Recent Developments in the Market:
In December 2021, US-based Pfizer has received FDA approval for its Tofacitinib. Tofacitinib is the first Janus kinase (JAK) inhibitor, or JAKi, that received approval for treatment of adults with active AS.
Global Ankylosing Spondylitis Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Drug Class, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Class
NSAIDs
TNF Inhibitors
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
The rising prevalence of Arthritis is contributing to the growth of the Global Ankylosing Spondylitis Market. For instance, according to Arthritis Foundation estimates – as of 2019, globally more than 54 million adults and approximately 300,000 children are affected by arthritis or another type of rheumatic disease. Moreover, increasing incidences of Ankylosing Spondylitis are also fueling up the growth of the Market. For instance, as per Spondylitis Association of America – as of 2020 more than 1.7 million adults in the U.S. are affected by AS. Whereas, around 3.2 million have a form of axial spondyloarthritis. Also, the rising number of orthopedic hospitals and diagnostic centers and growing healthcare infrastructure in developing regions would create lucrative growth prospects for the market over the forecast period. However, the high treatment cost associated with Ankylosing Spondylitis stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Ankylosing Spondylitis Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region in terms of market share due to factors such as the rising prevalence of Ankylosing Spondylitis as well as growing healthcare infrastructure in the region. Whereas the Asia Pacific is expected to grow with the highest CAGRduring the forecast period, owing to factors such as rising geriatric individuals as well as growing healthcare infrastructure in the region.
Major market player included in this report are:
AbbVie Inc.
Amgen, Inc,
Eli Lilly and Company
Gilead Sciences Inc.
Janssen Pharmaceuticals
Merck & Co. Inc
Novartis AG,
Pfizer, Inc
Reliance Life Sciences Pvt. Ltd
UCB, Inc.,
Recent Developments in the Market:
In December 2021, US-based Pfizer has received FDA approval for its Tofacitinib. Tofacitinib is the first Janus kinase (JAK) inhibitor, or JAKi, that received approval for treatment of adults with active AS.
Global Ankylosing Spondylitis Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Drug Class, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Class
NSAIDs
TNF Inhibitors
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Ankylosing Spondylitis Market, by Region, 2019-2029 (USD Billion)
1.2.2. Ankylosing Spondylitis Market, by Drug Class, 2019-2029 (USD Billion)
1.2.3. Ankylosing Spondylitis Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL ANKYLOSING SPONDYLITIS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL ANKYLOSING SPONDYLITIS MARKET DYNAMICS
3.1. Ankylosing Spondylitis Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Growing prevalence of Arthritis.
3.1.1.2. Growing incidences of Ankylosing Spondylitis
3.1.1.3. Strategic initiatives from leading market players
3.1.2. Market Challenges
3.1.2.1. High treatment cost of Ankylosing Spondylitis
3.1.3. Market Opportunities
3.1.3.1. Growing number of orthopedic hospitals and diagnostic centers
3.1.3.2. Rising healthcare infrastructure in developing regions.
CHAPTER 4. GLOBAL ANKYLOSING SPONDYLITIS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL ANKYLOSING SPONDYLITIS MARKET, BY DRUG CLASS
6.1. Market Snapshot
6.2. Global Ankylosing Spondylitis Market by Drug Class, Performance - Potential Analysis
6.3. Global Ankylosing Spondylitis Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
6.4. Ankylosing Spondylitis Market, Sub Segment Analysis
6.4.1. NSAIDs
6.4.2. TNF inhibitors
6.4.3. Others
CHAPTER 7. GLOBAL ANKYLOSING SPONDYLITIS MARKET, BY DISTRIBUTION CHANNEL
7.1. Market Snapshot
7.2. Global Ankylosing Spondylitis Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Ankylosing Spondylitis Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
7.4. Ankylosing Spondylitis Market, Sub Segment Analysis
7.4.1. Hospital pharmacy
7.4.2. Retail pharmacy
7.4.3. Online pharmacy
CHAPTER 8. GLOBAL ANKYLOSING SPONDYLITIS MARKET, REGIONAL ANALYSIS
8.1. Ankylosing Spondylitis Market, Regional Market Snapshot
8.2. North America Ankylosing Spondylitis Market
8.2.1. U.S. Ankylosing Spondylitis Market
8.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Ankylosing Spondylitis Market
8.3. Europe Ankylosing Spondylitis Market Snapshot
8.3.1. U.K. Ankylosing Spondylitis Market
8.3.2. Germany Ankylosing Spondylitis Market
8.3.3. France Ankylosing Spondylitis Market
8.3.4. Spain Ankylosing Spondylitis Market
8.3.5. Italy Ankylosing Spondylitis Market
8.3.6. Rest of Europe Ankylosing Spondylitis Market
8.4. Asia-Pacific Ankylosing Spondylitis Market Snapshot
8.4.1. China Ankylosing Spondylitis Market
8.4.2. India Ankylosing Spondylitis Market
8.4.3. Japan Ankylosing Spondylitis Market
8.4.4. Australia Ankylosing Spondylitis Market
8.4.5. South Korea Ankylosing Spondylitis Market
8.4.6. Rest of Asia Pacific Ankylosing Spondylitis Market
8.5. Latin America Ankylosing Spondylitis Market Snapshot
8.5.1. Brazil Ankylosing Spondylitis Market
8.5.2. Mexico Ankylosing Spondylitis Market
8.6. Rest of The World Ankylosing Spondylitis Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. AbbVie Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Amgen, Inc,
9.2.3. Eli Lilly and Company
9.2.4. Gilead Sciences Inc
9.2.5. Janssen Pharmaceuticals
9.2.6. Merck & Co. Inc
9.2.7. Novartis AG,
9.2.8. Pfizer, Inc
9.2.9. Reliance Life Sciences Pvt. Ltd
9.2.10. UCB, Inc.,
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Ankylosing Spondylitis Market, by Region, 2019-2029 (USD Billion)
1.2.2. Ankylosing Spondylitis Market, by Drug Class, 2019-2029 (USD Billion)
1.2.3. Ankylosing Spondylitis Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL ANKYLOSING SPONDYLITIS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL ANKYLOSING SPONDYLITIS MARKET DYNAMICS
3.1. Ankylosing Spondylitis Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Growing prevalence of Arthritis.
3.1.1.2. Growing incidences of Ankylosing Spondylitis
3.1.1.3. Strategic initiatives from leading market players
3.1.2. Market Challenges
3.1.2.1. High treatment cost of Ankylosing Spondylitis
3.1.3. Market Opportunities
3.1.3.1. Growing number of orthopedic hospitals and diagnostic centers
3.1.3.2. Rising healthcare infrastructure in developing regions.
CHAPTER 4. GLOBAL ANKYLOSING SPONDYLITIS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL ANKYLOSING SPONDYLITIS MARKET, BY DRUG CLASS
6.1. Market Snapshot
6.2. Global Ankylosing Spondylitis Market by Drug Class, Performance - Potential Analysis
6.3. Global Ankylosing Spondylitis Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
6.4. Ankylosing Spondylitis Market, Sub Segment Analysis
6.4.1. NSAIDs
6.4.2. TNF inhibitors
6.4.3. Others
CHAPTER 7. GLOBAL ANKYLOSING SPONDYLITIS MARKET, BY DISTRIBUTION CHANNEL
7.1. Market Snapshot
7.2. Global Ankylosing Spondylitis Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Ankylosing Spondylitis Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
7.4. Ankylosing Spondylitis Market, Sub Segment Analysis
7.4.1. Hospital pharmacy
7.4.2. Retail pharmacy
7.4.3. Online pharmacy
CHAPTER 8. GLOBAL ANKYLOSING SPONDYLITIS MARKET, REGIONAL ANALYSIS
8.1. Ankylosing Spondylitis Market, Regional Market Snapshot
8.2. North America Ankylosing Spondylitis Market
8.2.1. U.S. Ankylosing Spondylitis Market
8.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Ankylosing Spondylitis Market
8.3. Europe Ankylosing Spondylitis Market Snapshot
8.3.1. U.K. Ankylosing Spondylitis Market
8.3.2. Germany Ankylosing Spondylitis Market
8.3.3. France Ankylosing Spondylitis Market
8.3.4. Spain Ankylosing Spondylitis Market
8.3.5. Italy Ankylosing Spondylitis Market
8.3.6. Rest of Europe Ankylosing Spondylitis Market
8.4. Asia-Pacific Ankylosing Spondylitis Market Snapshot
8.4.1. China Ankylosing Spondylitis Market
8.4.2. India Ankylosing Spondylitis Market
8.4.3. Japan Ankylosing Spondylitis Market
8.4.4. Australia Ankylosing Spondylitis Market
8.4.5. South Korea Ankylosing Spondylitis Market
8.4.6. Rest of Asia Pacific Ankylosing Spondylitis Market
8.5. Latin America Ankylosing Spondylitis Market Snapshot
8.5.1. Brazil Ankylosing Spondylitis Market
8.5.2. Mexico Ankylosing Spondylitis Market
8.6. Rest of The World Ankylosing Spondylitis Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. AbbVie Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Amgen, Inc,
9.2.3. Eli Lilly and Company
9.2.4. Gilead Sciences Inc
9.2.5. Janssen Pharmaceuticals
9.2.6. Merck & Co. Inc
9.2.7. Novartis AG,
9.2.8. Pfizer, Inc
9.2.9. Reliance Life Sciences Pvt. Ltd
9.2.10. UCB, Inc.,
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Ankylosing Spondylitis Market, report scope
TABLE 2. Global Ankylosing Spondylitis Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Ankylosing Spondylitis Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
TABLE 4. Global Ankylosing Spondylitis Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 5. Global Ankylosing Spondylitis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Ankylosing Spondylitis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Ankylosing Spondylitis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Ankylosing Spondylitis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Ankylosing Spondylitis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Ankylosing Spondylitis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Ankylosing Spondylitis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Ankylosing Spondylitis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Ankylosing Spondylitis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Ankylosing Spondylitis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Ankylosing Spondylitis Market
TABLE 70. List of primary sources, used in the study of global Ankylosing Spondylitis Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Ankylosing Spondylitis Market, report scope
TABLE 2. Global Ankylosing Spondylitis Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Ankylosing Spondylitis Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
TABLE 4. Global Ankylosing Spondylitis Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 5. Global Ankylosing Spondylitis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Ankylosing Spondylitis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Ankylosing Spondylitis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Ankylosing Spondylitis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Ankylosing Spondylitis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Ankylosing Spondylitis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Ankylosing Spondylitis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Ankylosing Spondylitis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Ankylosing Spondylitis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Ankylosing Spondylitis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Ankylosing Spondylitis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Ankylosing Spondylitis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Ankylosing Spondylitis Market
TABLE 70. List of primary sources, used in the study of global Ankylosing Spondylitis Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Ankylosing Spondylitis Market, research methodology
FIG 2. Global Ankylosing Spondylitis Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Ankylosing Spondylitis Market, key trends 2021
FIG 5. Global Ankylosing Spondylitis Market, growth prospects 2022-2029
FIG 6. Global Ankylosing Spondylitis Market, porters 5 force model
FIG 7. Global Ankylosing Spondylitis Market, pest analysis
FIG 8. Global Ankylosing Spondylitis Market, value chain analysis
FIG 9. Global Ankylosing Spondylitis Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Ankylosing Spondylitis Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Ankylosing Spondylitis Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Ankylosing Spondylitis Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Ankylosing Spondylitis Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Ankylosing Spondylitis Market, regional snapshot 2019 & 2029
FIG 15. North America Ankylosing Spondylitis Market 2019 & 2029 (USD Billion)
FIG 16. Europe Ankylosing Spondylitis Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Ankylosing Spondylitis Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Ankylosing Spondylitis Market 2019 & 2029 (USD Billion)
FIG 19. Global Ankylosing Spondylitis Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Ankylosing Spondylitis Market, research methodology
FIG 2. Global Ankylosing Spondylitis Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Ankylosing Spondylitis Market, key trends 2021
FIG 5. Global Ankylosing Spondylitis Market, growth prospects 2022-2029
FIG 6. Global Ankylosing Spondylitis Market, porters 5 force model
FIG 7. Global Ankylosing Spondylitis Market, pest analysis
FIG 8. Global Ankylosing Spondylitis Market, value chain analysis
FIG 9. Global Ankylosing Spondylitis Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Ankylosing Spondylitis Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Ankylosing Spondylitis Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Ankylosing Spondylitis Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Ankylosing Spondylitis Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Ankylosing Spondylitis Market, regional snapshot 2019 & 2029
FIG 15. North America Ankylosing Spondylitis Market 2019 & 2029 (USD Billion)
FIG 16. Europe Ankylosing Spondylitis Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Ankylosing Spondylitis Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Ankylosing Spondylitis Market 2019 & 2029 (USD Billion)
FIG 19. Global Ankylosing Spondylitis Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
